AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0140
-0.0008 (-5.41%)
Jul 2, 2024, 3:38 PM EDT - Market closed
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $4.08 million as of July 3, 2024. Its market cap has decreased by -40.24% in one year.
Market Cap
4.08M
Enterprise Value
10.35M
1-Year Change
-40.24%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since July 3, 2019, AXIM Biotechnologies's market cap has decreased from $49.99M to $4.08M, a decrease of -91.84%. That is a compound annual growth rate of -39.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.87M | -15.22% |
| Dec 29, 2023 | 4.56M | -14.40% |
| Dec 30, 2022 | 5.33M | -91.63% |
| Dec 31, 2021 | 63.72M | 16.93% |
| Dec 31, 2020 | 54.50M | 98.93% |
| Dec 31, 2019 | 27.39M | -45.20% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.38B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |